Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
- 22 May 2007
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (21), 4301-4311
- https://doi.org/10.1016/j.vaccine.2007.02.057
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A decade of discoveries in veterinary protozoology changes our concept of “subclinical” toxoplasmosisVeterinary Parasitology, 2005
- Zoonotic protozoa: from land to seaTrends in Parasitology, 2004
- DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmissionVaccine, 2003
- Induction and Regulation of IL-12-Dependent Host Resistance to Toxoplasma gondiiImmunologic Research, 2003
- Protective Effects of Immunization with a Recombinant Cyst Antigen in Mouse Models of Infection withToxoplasma gondiiTissue CystsThe Journal of Infectious Diseases, 2002
- Central nervous system infections in individuals with HIV-1 infectionJournal of NeuroVirology, 2002
- Deficient Humoral Responses Underlie Susceptibility toToxoplasma gondiiin CD4-Deficient MiceInfection and Immunity, 2002
- B Cells Are Essential for Vaccination-Induced Resistance to VirulentToxoplasma gondiiInfection and Immunity, 2000
- A commercial vaccine for ovine toxoplasmosisParasitology, 1995
- Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondiiScience, 1988